Medelis Leadership

Robert T. Bosserman, J.D. – President, CEO & Chairman

Bob Bosserman has more than 30 years of experience in senior management of both large and small companies in high-technology industries, from computers to water purification to software to biotechnology. More …

E. Laughlin (Larry) Flanagan – Founder, Director

Larry Flanagan has over 30 years experience in senior management and was a principal founder of Medelis in 2003 and has served as Chief Administrative Officer since inception. More …

David Browning – Vice President, Clinical Operations

David Browning has over 14 years of clinical research experience, which includes extensive CRO experience leading Phase I – III clinical studies in the US. More …

Dr. Deirdre Tessman – Managing Director, Medelis Europe

Dr. Deirdre Tessman has more than 30 years of worldwide drug development and regulatory experience. She has directed all phases of pharmaceutical development from research through drug approval and marketing with additional expertise in the startup and turnaround of pharmaceutical companies. More …

Shawn Varrin – Director, Business Development

Shawn Varrin brings 20 years of medical research experience to Medelis, with a background in both preclinical and clinical research. Prior to joining Medelis, he was the president of VinCro Clinical Management Services, a full service CRO. More …

Dr. Mike McGarry – Vice President, Preclinical Studies

Dr. Mike McGarry is a preclinical research scientist with over 35 years of experience generating high quality animal-based data. More …

Dr. Inder Makin – Vice President, Devices & Radiological Health

Dr. Inder Makin has more than 20 years of experience developing healthcare technologies including medical devices, ultrasound, radio frequency, lasers, magnetic resonance and computer tomography. More …

Dr. John Grous – Vice President, Medical Affairs (Consultant)

John J. Grous, M.D. is a board-certified medical oncologist with extensive experience in cancer therapeutic drug development. More…

Raymond C. Lamy, MS – Vice President, Regulatory Affairs (Consultant)

Raymond Lamy has over twenty-five years of combined pharmaceutical/biotech industry experience in Regulatory Affairs, Clinical Statistical Programming, and and Nonclinical Research, focused on the development and marketing registration of prescription drug/biotechnology products in several therapeutic areas (i.e., oncology, CNS, pain management, anti-infective). More …